[Launois-Bensaude disease; etiopathogenic discussion in a patient treated with tuberculostatic agents].
D000328:Adult; D000995:Antitubercular Agents / Q000009:adverse effects* / Q000627:therapeutic use; D004977:Ethambutol / Q000009:adverse effects; D007839:Functional Laterality; D006801:Humans; D007538:Isoniazid / Q000009:adverse effects; D008068:Lipomatosis / Q000139:chemically induced*; D008297:Male; D012293:Rifampin / Q000009:adverse effects; D013577:Syndrome; D014397:Tuberculosis, Pulmonary / Q000150:complications / Q000188:drug therapy
D000995:Antitubercular Agents; D004977:Ethambutol; D007538:Isoniazid; D012293:Rifampin
Maladie de Launois-Bensaude discussion étiopathogénique chez un malade traité par tuberculostatiques